← Open Payments lookup

GREGORY MONTOYA: Open Payments

NPI 1083614176 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,227 in 197 payments from 11 companies in 2025. Trend: 2023 $1,289 · 2024 $1,898 · 2025 $3,227

Food & beverage: $3,227
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.39$713
Vanda Pharmaceuticals Inc.28$625
Neurocrine BioSciences, Inc.24$519
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)31$394
E.R. Squibb & Sons, L.L.C.16$290
Alkermes, Inc.15$249
ABBVIE INC.29$221
Teva Pharmaceuticals USA, Inc.11$137
Janssen Pharmaceuticals, Inc2$39
IDORSIA PHARMACEUTICALS US INC1$23

Products named: REXULTI, FANAPT, INGREZZA, CAPLYTA, COBENFY, ARISTADA, VRAYLAR, UZEDY.

Industry payments across TX — which companies pay providers there.